Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00563810 | Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of MYO-029 | PHASE1 | COMPLETED | 72 | — | — | Oct 1, 2004 | Apr 1, 2006 | Nov 26, 2007 | - | — |
| Name | Type | Description |
|---|---|---|
| MYO-029 | DRUG | - |
Inclusion Criteria: * Men aged 18 to 45 years inclusive on study day 1. * Elderly men and women aged 65 to 80 years inclusive on study day 1. * Women must be postmenopausal for \> or = 1 year (with estradiol \< 25 pg/mL and an FSH \> 40 mIU/mL). * Healthy as determined by the investigator on the ba...